2,513 results match your criteria: "New York CV; Nassau University Medical Center[Affiliation]"

Variants in seven genes (LRRK2, GBA1, PRKN, SNCA, PINK1, PARK7 and VPS35) have been formally adjudicated as causal contributors to Parkinson's disease; however, individuals with Parkinson's disease are often unaware of their genetic status since clinical testing is infrequently offered. As a result, genetic information is not incorporated into clinical care, and variant-targeted precision medicine trials struggle to enrol people with Parkinson's disease. Understanding the yield of genetic testing using an established gene panel in a large, geographically diverse North American population would help patients, clinicians, clinical researchers, laboratories and insurers better understand the importance of genetics in approaching Parkinson's disease.

View Article and Find Full Text PDF

Percutaneous coronary intervention versus coronary artery bypass grafting for left main disease according to age: A meta-analysis.

J Thorac Cardiovasc Surg

July 2024

Division of Cardiology, Cardiovascular and Thoracic Department, AOU Città della Salute e della Scienza di Torino and Department of Medical Sciences, University of Turin, Turin, Italy.

View Article and Find Full Text PDF
Article Synopsis
  • * The study found that anemia linked to higher risks for all-cause and cardiovascular hospitalizations, with significant statistics demonstrating this correlation.
  • * Despite the correlation, when adjusting for age and other factors, anemia was mainly associated with an increased hazard for hospitalizations rather than mortality, highlighting the need for more research on how treating anemia might improve patient outcomes.
View Article and Find Full Text PDF

International consensus on fasting terminology.

Cell Metab

August 2024

Institute of Social Medicine, Epidemiology and Health Economics, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, 10117 Berlin, Germany; Department of Internal Medicine and Nature-Based Therapies, Immanuel Hospital Berlin, 14109 Berlin, Germany.

Although fasting is increasingly applied for disease prevention and treatment, consensus on terminology is lacking. Using Delphi methodology, an international, multidisciplinary panel of researchers and clinicians standardized definitions of various fasting approaches in humans. Five online surveys and a live online conference were conducted with 38 experts, 25 of whom completed all 5 surveys.

View Article and Find Full Text PDF

Discontinuation versus continuation of statins: A systematic review.

J Am Geriatr Soc

November 2024

Department of Anesthesiology, Pharmacology, and Therapeutics, Faculty of Medicine, University of British Columbia, Vancouver, British Columbia, Canada.

Article Synopsis
  • Clinicians and patients often need to decide whether to continue or stop taking statins, and this study investigates the effects of such decisions on health outcomes like mortality and quality of life.* -
  • Researchers conducted a systematic review of various studies on statin use and found that discontinuing statins might be linked to a higher risk of overall and cardiovascular mortality as well as cardiovascular events, especially in non-randomized studies.* -
  • The only randomized controlled trial included had limited findings, showing no significant difference in short-term mortality for those who stopped statins, while results for older adults (≥75 years) were consistent with the overall trends observed.*
View Article and Find Full Text PDF

A novel ternary deep eutectic solvent (TDES), consisting of zinc chloride, ethylene glycol and alpha hydroxy carboxylic acids (i.e., glycolic acid, citric acid and malic acid), was first proposed to effectively fractionate and convert willow (Salix matsudana cv.

View Article and Find Full Text PDF
Article Synopsis
  • Device-related thrombosis (DRT) occurs frequently after left atrial appendage closure (LAAC), with notable differences in diagnosis timing and outcomes between men and women.
  • Women make up 34.7% of DRT patients in the study and tend to be older and have fewer comorbidities compared to men, but DRT in women is diagnosed significantly later.
  • Both genders have similar treatment outcomes and overall mortality rates, indicating that treatment strategies are equally effective regardless of sex.
View Article and Find Full Text PDF

The number of assays on highly-multiplexed proteomic platforms has grown tenfold over the past 15 years from less than 1,000 to >11,000. The leading aptamer-based and antibody-based platforms have different strengths. For example, Eldjarn et al demonstrated that the aptamer-based SomaScan 5k (4,907 assays, assessed in the Icelandic 36K) and the antibody-based Olink Explore 3072 (2,931 assays, assessed in the UK BioBank) had a similar number of -pQTLs among all targets (2,120 vs.

View Article and Find Full Text PDF

Introduction: High-risk percutaneous coronary interventions (HRPCI) are a potential treatment option for patients with reduced left ventricular ejection fraction (LVEF) and coronary artery disease. The extent to which such intervention is coupled with improvement in LVEF and associated with favorable outcomes is unknown.

Methods: We aimed to characterize the incidence and correlates of LVEF improvement after Impella-guided HRPCI, and compare clinical outcomes in patients with versus without LVEF improvement.

View Article and Find Full Text PDF

Plasma levels of myeloperoxidase and resistin independently predict mortality in dialysis patients.

Eur J Intern Med

November 2024

IRCCS Ospedale Policlinico San Martino, Genoa - Italian Cardiovascular Network, 10 Largo Rosanna Benzi, 16132 Genoa, Italy; First Clinic of Internal Medicine, Department of Internal Medicine, University of Genoa, 6 viale Benedetto XV, 16132 Genoa, Italy. Electronic address:

Background: In patients with kidney failure (KF) undergoing dialysis, neutrophils are dysfunctionally activated. Such chronic activation does not correspond to increased protection against infections and is thought to cause direct vascular damage accounting for the higher incidence of cardiovascular (CV) events. We hypothesized that circulating levels of neutrophil degranulation products (i.

View Article and Find Full Text PDF

Introduction: Metabolic dysfunction-associated steatotic liver disease (MASLD) is linked to increased cardiovascular (CV) risks, notably congestive heart failure (CHF). We evaluated the influence of MASLD on CHF and mortality among hospitalized cirrhotic patients.

Methods: We analyzed the National Inpatient Sample from 2016 to 2020, identifying adult cirrhosis patients.

View Article and Find Full Text PDF

What is the vibration of effects?

BMJ Evid Based Med

January 2025

Univ Rennes, CHU Rennes, Inserm, EHESP, Irset (Institut de recherche en santé, environnement et travail) - UMR_S 1085, Centre d'investigation clinique de Rennes (CIC1414), Rennes, France.

View Article and Find Full Text PDF

Objective: To evaluate the technical accuracy, inheritance, and pathogenicity of small copy number variants (CNVs) detected by a targeted next-generation sequencing-based preimplantation genetic testing for aneuploidy (PGT-A) platform.

Design: Retrospective observational study performed between 2020 and 2022.

Setting: Clinic.

View Article and Find Full Text PDF

Pulmonary artery catheter use and in-hospital outcomes in cardiac surgery: a systematic review and meta-analysis.

Interdiscip Cardiovasc Thorac Surg

July 2024

Department of Cardiothoracic Surgery, Weill Cornell Medicine, New York, NY, USA.

Article Synopsis
  • The study aims to evaluate how the use of pulmonary artery catheters (PACs) during cardiac surgery affects patient outcomes in the hospital.
  • It analyzed data from seven studies involving over 25,000 patients, finding that PAC use is linked to a higher risk of in-hospital mortality and longer stays in intensive care.
  • The findings indicate a clear need for further research, particularly randomized trials, to better understand the impact of PAC on cardiac surgery patients' health outcomes.
View Article and Find Full Text PDF

Ischemia Severity, Coronary Artery Disease Extent, and Exercise Capacity in ISCHEMIA.

Circulation

July 2024

Cardiovascular Clinical Research Center, Leon H. Charney Division of Cardiology, Department of Medicine, NYU Grossman School of Medicine, New York, NY (H.R.R., J.S.B., L.M.P., S.B., J.S.H.).

View Article and Find Full Text PDF

Heart failure (HF) patients frequently exhibit iron deficiency, which is associated with a poor prognosis. Although various trials have been conducted, it is uncertain if intravenous (IV) iron replenishment improves clinical outcomes in HF patients with iron deficiency. A comprehensive literature search was conducted using PubMed/MEDLINE, Embase, and the Cochrane Library from inception till 15 September 2023 to retrieve randomized controlled trials (RCTs) that compared IV iron therapy with placebo or standard of care in patients with HF and iron deficiency.

View Article and Find Full Text PDF

Alirocumab and cardiovascular outcomes according to sex and lipoprotein(a) after acute coronary syndrome: a report from the ODYSSEY OUTCOMES study.

J Clin Lipidol

August 2024

CPC Clinical Research and Division of Cardiology, University of Colorado School of Medicine, Aurora, CO (Dr Szarek); State University of New York, Downstate Health Sciences University, Brooklyn, NY (Dr Szarek).

Article Synopsis
  • - The ODYSSEY OUTCOMES trial evaluated the impact of alirocumab, a drug that targets cholesterol, compared to a placebo on major cardiovascular events in patients with recent acute coronary syndrome, involving over 18,000 participants.
  • - Results showed that while both men and women experienced significant reductions in cholesterol levels and cardiovascular events with alirocumab, women had higher initial cholesterol and lipoprotein(a) levels and more co-morbidities.
  • - The study concluded that alirocumab improves cardiovascular outcomes post-acute coronary syndrome for both sexes, especially in individuals with higher baseline levels of lipoprotein(a).
View Article and Find Full Text PDF
Article Synopsis
  • * Many patients with serious symptoms of TR are included in clinical trials for new transcatheter devices, indicating they may be at an advanced stage of HFpEF.
  • * The review explores how treating HFpEF could influence TR's underlying issues and how changes after transcatheter TR treatment might improve symptoms and outcomes for HFpEF patients.
View Article and Find Full Text PDF

The increasing aging of the population combined with improvements in cancer detection and care has significantly improved the survival and quality of life of cancer patients. These benefits are hampered by the increase of cardiovascular diseases being heart failure the most frequent manifestation of cardiotoxicity and becoming the major cause of morbidity and mortality among cancer survivor. Current strategies to prevent cardiotoxicity involves different approaches such as optimal management of CV risk factors, use of statins and/or neurohormonal medications, and, in some cases, even the use of chelating agents.

View Article and Find Full Text PDF

Natural killer (NK) cells are innate lymphoid cells (ILCs) contributing to immune responses to microbes and tumors. Historically, their classification hinged on a limited array of surface protein markers. Here, we used single-cell RNA sequencing (scRNA-seq) and cellular indexing of transcriptomes and epitopes by sequencing (CITE-seq) to dissect the heterogeneity of NK cells.

View Article and Find Full Text PDF

Our ability to calculate rate constants of biochemical processes using molecular dynamics simulations is severely limited by the fact that the time scales for reactions, or changes in conformational state, scale exponentially with the relevant free-energy barrier heights. In this work, we improve upon a recently proposed rate estimator that allows us to predict transition times with molecular dynamics simulations biased to rapidly explore one or several collective variables (CVs). This approach relies on the idea that not all bias goes into promoting transitions, and along with the rate, it estimates a concomitant scale factor for the bias termed the "CV biasing efficiency" γ.

View Article and Find Full Text PDF

Pathophysiology of Preeclampsia-Induced Vascular Dysfunction and Implications for Subclinical Myocardial Damage and Heart Failure.

JACC Adv

June 2024

Raquel and Jaime Gilinski Department of Obstetrics, Gynecology, and Reproductive Science, New York, New York, USA.

Article Synopsis
  • - Preeclampsia is a major pregnancy complication that significantly increases the risk of cardiovascular disease (CVD) for both mothers and infants, especially among Black women.
  • - Early preeclampsia, occurring before 34 weeks of gestation, leads to systemic vascular issues that can cause lasting heart damage and pose long-term risks for heart failure (HF).
  • - It’s important for women who experienced early or severe preeclampsia to receive careful monitoring after pregnancy to manage chronic hypertension and decrease the risks of CVD and HF.
View Article and Find Full Text PDF

Background: Persons with COVID-19 infection have an increased risk of pregnancy-related complications. However, data on acute cardiovascular (CV) complications during delivery admissions remain limited.

Objectives: The purpose of this study was to determine whether pregnant individuals with COVID-19 have an increased risk of acute peripartum CV complications during their delivery admission.

View Article and Find Full Text PDF

Impact of cannabidiol on myocardial recovery in patients with acute myocarditis: Rationale & design of the ARCHER trial.

ESC Heart Fail

October 2024

Department of Cardiology, Angiology and Intensive Medicine, Deutsches Herzzentrum der Charité (DHZC), Campus Virchow (CVK), Berlin, Germany.

Aims: Acute myocarditis, although a rare disease, can be associated with sudden cardiac death or the need for transplantation in both children and young adults. To date, there is no definitive evidence to support the routine use of immunosuppressive therapy or treatment targeting inflammation in patients with myocarditis. Animal models of cardiovascular (CV), as well as neurological diseases, have demonstrated that cannabidiol has significant anti-inflammatory properties and may represent a promising therapy in acute myocarditis.

View Article and Find Full Text PDF